Determining the functional role of TRPC channels in primary cells
Su Li1, Martin Gosling, Chris Poll
1Novartis Institutes for Biomedical Research, Novartis Respiratory Research Centre, Wimblehurst Road, Horsham, West Sussex, RH12 5AB, UK. su.li@novartis.com
Pflugers Archiv : European Journal of Physiology
|August 4, 2005
Summary
Transient Receptor Potential Canonical (TRPC) channels, though discovered early, are less understood than other TRP channels. Overcoming TRPC complexities offers opportunities for novel respiratory disease therapies.
Area of Science:
- Molecular biology
- Physiology
- Pharmacology
Background:
- Mammalian Transient Receptor Potential Canonical (TRPC) channels were identified in 1995.
- Knowledge of TRPC channels lags behind TRPV and TRPM subfamilies.
- TRPC channel complexities have limited their therapeutic development.
Purpose of the Study:
- To review the challenges and opportunities in targeting TRPC channels for drug discovery.
- To highlight the potential of TRPC channels in treating respiratory diseases.
Main Methods:
- Literature review of TRPC channel research.
- Analysis of TRPC channel composition and regulation complexities.
- Discussion of therapeutic potential in respiratory diseases.
Main Results:
- TRPC channel research faces significant hurdles in composition and regulation understanding.
- These challenges present opportunities for innovative therapeutic strategies.
- TRPC channels show promise as targets for respiratory disease treatments.
Conclusions:
- Despite complexities, TRPC channels are promising therapeutic targets.
- Further research into TRPC channel function is crucial for drug discovery.
- Targeting TRPC channels could lead to novel treatments for respiratory conditions.
